Trial Profile
[Targetspezifische Second-line-Therapie des metastasierten Urothelkarzinoms mit Temsirolimus] Target-specific therapy of metastatic urothelial carcinoma with temsirolimus
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- 07 Jul 2011 New trial record